Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Prokidney Corp (DNAA)

Prokidney Corp (DNAA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 360,755
  • Shares Outstanding, K 25,640
  • Annual Sales, $ 0 K
  • Annual Income, $ -2,440 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta -0.02
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on 08/12/22
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.07 +55.13%
on 08/17/22
17.44 -19.32%
on 08/19/22
+4.16 (+41.98%)
since 07/19/22
3-Month
9.07 +55.13%
on 08/17/22
17.44 -19.32%
on 08/19/22
+4.23 (+42.99%)
since 05/19/22
52-Week
9.07 +55.13%
on 08/17/22
17.44 -19.32%
on 08/19/22
+4.23 (+42.99%)
since 08/19/21

Most Recent Stories

More News
PureTech Health plc – Half-Year Report

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”) today announces its half-yearly results for the six months ended June 30, 2022. The following information will be filed...

PRTC : 21.78 (+0.39%)
PRTC.LN : 162.000 (+0.12%)
AKLI : 0.4320 (-0.62%)
GLS : 0.1586 (+0.38%)
DNAA : 14.07 (+47.02%)
RBLX : 49.35 (-4.21%)
CPSR : 7.36 (+9.85%)
KRTX : 329.83 (+0.03%)
VOR : 0.7961 (+0.16%)
Digital Medicine Leader Akili to List on Nasdaq Following Successful Business Combination with Social Capital Suvretta Holdings Corp. I

Akili, a leading digital medicine company, today completed its previously announced business combination with Social Capital Suvretta Holdings Corp. I (“SCS”) (Nasdaq: DNAA), a publicly traded special...

DNAA : 14.07 (+47.02%)
PureTech Founded Entity Akili Announces Public Company Board of Director Nominees

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company noted that its Founded Entity, Akili Interactive Labs, Inc. (“Akili”),...

PRTC : 21.78 (+0.39%)
PRTC.LN : 162.000 (+0.12%)
DNAA : 14.07 (+47.02%)
Akili Announces Public Company Board of Director Nominees

Akili Interactive (“Akili”), a leading digital medicine company pioneering the development of cognitive treatments through game-changing technologies, today announced the nominees for its future board...

DNAA : 14.07 (+47.02%)
Akili Integrates First-of-its-Kind Prescription Video Game Treatment with the Virtual World Through Partnership with Roblox

Akili Interactive (“Akili”), a leading digital medicine company pioneering the development of cognitive treatments through game-changing technologies, and Roblox (NYSE: RBLX), a global platform...

DNAA : 14.07 (+47.02%)
RBLX : 49.35 (-4.21%)
PureTech Announces Annual Results for Year Ended December 31, 2021

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines...

PRTC : 21.78 (+0.39%)
PRTC.LN : 162.000 (+0.12%)
DNAA : 14.07 (+47.02%)
CPSR : 7.36 (+9.85%)
PureTech Founded Entity Akili Announces American Journal of Psychiatry Publication of Data Demonstrating its Digital Therapeutic AKL-T03 Improves Cognitive Impairments in Adults w/ Major Depressive Disorder When Combined w/ Antidepressant Medication

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company noted that its Founded Entity, Akili Interactive Labs, Inc. (“Akili”),...

PRTC : 21.78 (+0.39%)
PRTC.LN : 162.000 (+0.12%)
DNAA : 14.07 (+47.02%)
The American Journal of Psychiatry Publishes Data Demonstrating Akili Interactive’s Digital Therapeutic AKL-T03 Improves Cognitive Impairments in Adults with Major Depressive Disorder When Combined with Antidepressant Medication

Akili Interactive (“Akili”), a leading cognitive medicine company improving health through game-changing technologies, today announced that the American Journal of Psychiatry has published findings...

DNAA : 14.07 (+47.02%)
Akili to Present at Chardan’s Prescription Digital Therapeutics Half-Day Summit

Akili Interactive (“Akili” or the “Company”), a leading digital medicine company pioneering the development of cognitive treatments through game-changing technologies, today announced that management...

DNAA : 14.07 (+47.02%)
PureTech Founded Entity Akili Appoints Game Industry Veteran Behind Bejeweled, Plants vs. Zombies as Chief Product Officer

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company noted that its Founded Entity, Akili Interactive Labs, Inc. (“Akili”),...

PRTC : 21.78 (+0.39%)
PRTC.LN : 162.000 (+0.12%)
DNAA : 14.07 (+47.02%)

Business Summary

Social Capital Suvretta Holdings Corp. I is a blank check company. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or related business combination with one or more businesses. The Company intends to focus on businesses operating in the biotechnology...

See More

Key Turning Points

3rd Resistance Point 25.81
2nd Resistance Point 21.62
1st Resistance Point 17.85
Last Price 14.07
1st Support Level 9.89
2nd Support Level 5.70
3rd Support Level 1.93

See More

52-Week High 17.44
Fibonacci 61.8% 14.24
Last Price 14.07
Fibonacci 50% 13.26
Fibonacci 38.2% 12.27
52-Week Low 9.07

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar